Results 181 to 190 of about 16,632 (221)
Some of the next articles are maybe not open access.
Neurogenic orthostatic hypotension: chasing “the fall”
Postgraduate Medical Journal, 2008Abstract Orthostatic hypotension (OH) is a frequently encountered problem affecting nearly 30% of the population aged more than 60 years. It can result from neurological and non-neurological derangements which compromise the perfusion of the brain in an erect posture. Neurogenic OH is a manifestation of autonomic failure.
D, Gupta, M D, Nair
openaire +2 more sources
Neurodegenerative Disease Management, 2022
Aim: This study explores the burden of caring for an individual with neurogenic orthostatic hypotension (nOH) and an underlying neurodegenerative disease (Parkinson's disease, multiple system atrophy, pure autonomic failure or dementia with Lewy bodies).
K. Gallop +6 more
semanticscholar +1 more source
Aim: This study explores the burden of caring for an individual with neurogenic orthostatic hypotension (nOH) and an underlying neurodegenerative disease (Parkinson's disease, multiple system atrophy, pure autonomic failure or dementia with Lewy bodies).
K. Gallop +6 more
semanticscholar +1 more source
Pyridostigmine for the Management of Neurogenic Orthostatic Hypotension: A Systemic Review
Journal of Geriatric Psychiatry and NeurologyBackground Pyridostigmine is hypothesized to improve neurogenic orthostatic hypotension (nOH) symptoms without causing or exacerbating supine hypertension.
Amanda C Holder +2 more
semanticscholar +1 more source
HYPERTENSION, 2022
Patients with neurogenic orthostatic hypotension (NOH) are at risk for syncope, falls and have poor quality of life. Only two drugs (midodrine, droxidopa) are FDA-approved for the treatment of NOH.
V. Urechie +6 more
semanticscholar +1 more source
Patients with neurogenic orthostatic hypotension (NOH) are at risk for syncope, falls and have poor quality of life. Only two drugs (midodrine, droxidopa) are FDA-approved for the treatment of NOH.
V. Urechie +6 more
semanticscholar +1 more source
Circulation
Introduction: Droxidopa (DD) is the second FDA approved drug after midodrine for neurogenic orthostatic hypotension (nOH). Isaacon et al reported that 19 (5.4%) of total 350 patients on droxidopa had 25 cardiac events, most commonly atrial ...
Y. N. Htay +7 more
semanticscholar +1 more source
Introduction: Droxidopa (DD) is the second FDA approved drug after midodrine for neurogenic orthostatic hypotension (nOH). Isaacon et al reported that 19 (5.4%) of total 350 patients on droxidopa had 25 cardiac events, most commonly atrial ...
Y. N. Htay +7 more
semanticscholar +1 more source
Neuropharmacologic Distinction of Neurogenic Orthostatic Hypotension Syndromes
Clinical Neuropharmacology, 2006Neurogenic orthostatic hypotension (OH) characterizes pure autonomic failure (PAF), multiple system atrophy (MSA), and Parkinson disease (PD) with autonomic failure. We used neuropharmacologic probes that might distinguish these diseases based on loss of sympathetic noradrenergic nerves in PAF and PD + OH but not in MSA, and related the results to ...
Yehonatan, Sharabi +6 more
openaire +2 more sources
Carbon Dioxide as a Novel Blood Pressure Therapy for Neurogenic Orthostatic Hypotension
PhysiologyBACKGROUND: On standing, people with neurogenic orthostatic hypotension (nOH) experience plummeting blood pressure (>20/10mmHg), crippling symptoms, and syncope. Current blood pressure therapies lack effcacy and have serious side effects.
J. Baker +6 more
semanticscholar +1 more source
An older rehabilitation inpatient with severe neurogenic orthostatic hypotension: a case report
Journal of Aging and RehabilitationThis case reports the inpatient rehabilitation course of an 81-year-old male patient with a traumatic brain injury resulting from severe neurogenic orthostatic hypotension (OH).
Ben Ariel, Valerie Soloveichik, A. Bilek
semanticscholar +1 more source
Archives of Internal Medicine, 1984
The maintenance of adequate upright BP requires both a baroreceptor-mediated feedback loop and an effective circulating blood volume. Although functional disruptions of these mechanisms are reversible and common, several permanent and often progressive neurologic disorders exist that interfere with necessary reflexes and orthostatic BP control ...
openaire +2 more sources
The maintenance of adequate upright BP requires both a baroreceptor-mediated feedback loop and an effective circulating blood volume. Although functional disruptions of these mechanisms are reversible and common, several permanent and often progressive neurologic disorders exist that interfere with necessary reflexes and orthostatic BP control ...
openaire +2 more sources
Journal of the Korean Neurological Association
Background: To investigate the patterns of blood pressure (BP) decrement during the tilt, to compare the pattern of orthostatic hypotension (OH) and sympathetic index (SI) from the Valsalva maneuver (VM), and to identify whether the pattern of OH can ...
Jae-Joon Lee, Hyung Lee, H. Kim
semanticscholar +1 more source
Background: To investigate the patterns of blood pressure (BP) decrement during the tilt, to compare the pattern of orthostatic hypotension (OH) and sympathetic index (SI) from the Valsalva maneuver (VM), and to identify whether the pattern of OH can ...
Jae-Joon Lee, Hyung Lee, H. Kim
semanticscholar +1 more source

